• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/46

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

46 Cards in this Set

  • Front
  • Back
Adenosine - Class
Endogenous nucleotide
Adenosine - trade name
Adeonocard
Adenosine

Indications
Conversion of PSVT to sinus
May not convert reentry SVT do to wolff parkinson-white syndrome
Adenosine

Mechaanism of action
Slows time through AV node. Interrupts re0entrant pathways.

Slows HR, acts on sinus pacemaker. SVT and Wide complex Tach.
Adenosine

Contraindication
2nd and 3rd degree blocks or sick sinus syndrome. Afib/flutter, v-tach, hyp-sensitivity to adenosine, poison-induced tach
Adenosine

Adverse reactions
Facial flushing, SOB, angina, Headache, Parasthesia, Diaphoresis, Palpations, HYPOtension, Nausea
Adenosine

Adult Dose
6mg - 1 to 3 sec push w/20 ml Saline - raised extremity.
RPT - 1-2 min 12mg w/20ml saline - 30mg max
Adenosine

PEDS Dose
.1 to .2 mg/Kg bolus
Max 12 mg
Adenosine

Onset / duration / peak
onset / peak - immediate w/i seconds.
duration about 12 seconds
Atropine sulfate

Class
Anticholinengic agent
Atropine sulfate

Mechanism of Action
parasympatholic: inhibits action of acetylcholine at postganglionic parasympathetic neuroeddector site. Increases HR in life threatening brdaycardia
Atropine sulfate

indications
hemodynamicly unstable brady, asystole, bradycardic (<60bpm) PEA, Prganophosphate poisoning, bronchopastic pulmonary disorders
Atropine sulfate

ContraIndications
Tachycardia, hypersensitivity, unstable cardiovascular status in acure hemorrage and myocardial ischemia, narow angle glaucoma
Atropine sulfate

Adverse Reactions
headache,dizzyness, palpations; nausea and vomitting, dry mouth, urinary retention
paradoxial bradycardia when pushed slowly or at low doses; fushed, hot, dry skin
Atropine sulfate

Drug interactions
digitoxin, cholinergincs, physostigmine. effects enhanced by antihistamines, procainamide, quinidine, antipsychotics, benzodiazepines, and antidepressants
Atropine sulfate

Adult Dose
-Asystole or brady PEA: 1mg IV/IO push. rpt 3 to 5min. max 3 doses.
-ET admin -2-3 mg diluted in 10ml of H2O or saline,
-unstabel brady: .5mg Iv/IO every 3 to 5 min asneeded not to exceede 3mg. Use shoter intervals and higer dose in severe cases.
Organophosphate poisoning - extremly large doses - 2-4mg may be needed.
Unstable
Atropine sulfate

Peds Dose
.02 mg/Kg IV/IO push; double 2nd time. min .01mg/Kg max single: .5mg, child total: 1mg, adolecent single- 1mg total: 2mg.
ET admin - .03 mg/Kg
Atropine sulfate

Duration of action
Onset: immediate
peak: rapid 1 to 2 min
durtion 2-6 hrs
Amiodarone

Class
Antiarrythythmic
Amiodarone

Trade name(s)
Cordarone, pacacerone
Amiodarone

Mechanism of action
Blocks sodium channels and myocardial K+ channels
Amiodarone

Indications
v-fib
pulseless v-tach
Amiodarone

contraindications
known hypersensitivity; cardiogenic shock, sinus brady, 2nd & 3rd degree AV block (unless functional pacemaker)
Amiodarone

Adverse reactions
Hypotension, brady, prolongation of the p-r, QRS and QT intervals
Amiodarone

Drug interactions
digoxin - cause toxicity
antiarrythmics - increase serum levels
betablockers and Ca channel blockers - potentiate brady, sinus arrest and AV blocks
Amiodarone

Adult Dose
v-fib/ PVT - 300mg IV/IO push
(recomend dilution in 20-30 ml D5W)folloowd 1x in 3 - 5 min 150mg IV/IO push
-Reoccurent life threatening -emergencies: 150mg - IV/IO over 10min rpt every 10min
Slow infusion 360mg over 6 hrs, maintenance - 540 over 18
Amiodarone

Peds
refractory v-fib.pvt - 5mg/Kg bolus - prt 5mg/Kg bolus up to 15mg/Kg/24hrs. max single 300mg
perfusing supraventicular and ventricular tachycardias - loading 5mg/Kg over 20-60min (max300mg) prt max of 15mg/kg/day
Amiodarone

Duration of Action
Onset: immediate
Peak: 10 to 15min
Duration: 30 - 45 min
Asprin

Class
Platelet inhibitor, anti-inflammatory agent
Asprin

Mechanism of Action
prostaglandin inhibition
Asprin

Indicatons
new onset angina - for MI. signs and symptoms of CVA
Asprin

contraindications
hypersestivity, ulsers and asthma
Asprin

Adverse Reactions
heartburn, gi bleeding, prolonged bleeding, nausea, emesis, wheezing (alergic)
Asprin

Drug interactions
allergy to NSAIDs
Asprin

Dose
160 to 325mg PO chewed if possible
Asprin

duration of action
onset 30-45min
peak variable
duration variable
epinephrine

(chemical name)
Adrenaline
epinephrine

class
sympathmimetic
epinephrine

mechanism of action
direct acting alpha and beta agonist. alpha: vasoconstriction. beta-1 positive inotropic chronotropic and dromotropic effects. Beta-2 bronchial smooth muscle relaxation and dilation of skeletal
epinephrine

indications
cardiac arrect (v-fib/pulseless v-tach, asystole, PEA) symptomatic bradycardia as an alt. infusion to dopamine. Severe HTN, secondary to brady when atropine and transcutaneous pacing are unsuccessful, allergic reactions, anaphylaxis, asthma
epinephrine

contraindications
htn, hypothermia, pulmonary edema, myocardial ischemia, hypovolemic shock
epinephrine

adverse reactions
htn, tach, arrythmias, pulomanry myocardial edema, anxiety, restlessness, psychomotor agitation, nausea, headache, angina
epinephrine

drug interactions
potentiates other sympathominetics, deactivated by alkaline solutions (ie. soduim bicarbonate), monamine oxidase inhibitors, (MAOIs) may potentiate effects, beta blockers may have blunt effects.
epinephrine

how supplied
1 to 1000 solution

1 to 10,000
epinephrine

ADULT
dosage and administration
mild allergic reactions and asthma: .3 to .5 ml of 1 to 1000 IV/IO over 5 min.
Cardiac Arrect IV/IO dose 1 mg (10ml of 1 to 10000) every 3 to 5 min. followed with bolus of 20ml saline
epinephrine

duration of action
onset: immediate
peak : minutes
duration: several min